Optimal Compatibility of Main Effective Parts of Astragali Radix‐Safflower for the Treatment of Cerebral Ischemia/Reperfusion by Pharmacokinetics‐Pharmacodynamics Analysis Based on Microdialysis and Liquid Chromatography–Tandem Mass Spectrometry
Phytochemical Analysis · 2026
DOI: 10.1002/pca.70055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemical Analysis, 2026. Verfasst von Xinyu Dong und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Carthamus tinctorius, Tandem Mass Spectrometry, Drugs, Chinese Herbal, Reperfusion Injury. Die Arbeit nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose
To research the therapeutic effect and compatibility mechanism of Astragali Radix‐Safflower (ARSA) main effective parts in cerebral ischemia/reperfusion injury (CI/RI), especially pharmacokinetics and pharmacodynamics study.
Method
Nine formulas of three main effective parts (total flavonoids of Astragali Radix, total saponins of Astragali Radix and safflower yellow pigment) of ARSA were formulated according to L 9 (3 4 ) orthogonal design. The sample collection was performed via blood–brain dual‐channel microdialysis, combined with LC–MS/MS to quantify six components (hydroxysafflor yellow A, astragaloside IV, calycosin‐7‐O‐β‐D‐glucopyranoside, ononin, calycosin, and formononetin) of ARSA and five neurotransmitters (aspartic acid, 5‐hydroxytryptamine, γ‐aminobutyric acid, dopamine, and glutamate) associated with CI/RI. The entropy weight method and the partial least square method were applied to analyze data.
Results
The best compatibility prescription of the main effective parts of ARSA was total flavonoids of Astragali Radix 600 mg/kg, total saponins of Astragali Radix 140 mg/kg, and safflower yellow pigment 840 mg/kg, which had a better therapeutic effect and the largest total area under the curve than other formulas. Undergoing CI/RI, glutamate was primarily regulated among the five neurotransmitters, and the components with the greater impact on neurotransmitter modulation were hydroxysafflor yellow A and astragaloside IV.
Conclusion
The different compatibility of effective parts of traditional Chinese medicine would influence the pharmacokinetics parameters of each active component in CI/RI rats. Orthogonal compatibility and total statistical moment method provided a way to find the best compatibility. This study provided a pattern for the exploration of traditional Chinese medicine compatibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
- School of Basic Medicine Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
ORCID-Profile: Yu He
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Dong, X., Zhou, P., Lou, Q., Li, C., Du, Y., & He, Y. (2026). Optimal Compatibility of Main Effective Parts of Astragali Radix‐Safflower for the Treatment of Cerebral Ischemia/Reperfusion by Pharmacokinetics‐Pharmacodynamics Analysis Based on Microdialysis and Liquid Chromatography–Tandem Mass Spectrometry. Phytochemical Analysis. https://doi.org/10.1002/pca.70055
Vancouver
Dong X, Zhou P, Lou Q, Li C, Du Y, He Y. Optimal Compatibility of Main Effective Parts of Astragali Radix‐Safflower for the Treatment of Cerebral Ischemia/Reperfusion by Pharmacokinetics‐Pharmacodynamics Analysis Based on Microdialysis and Liquid Chromatography–Tandem Mass Spectrometry. Phytochemical Analysis. 2026. doi:10.1002/pca.70055
BibTeX
@article{Dong2026,
author = {Dong, Xinyu and Zhou, Peng and Lou, Qiaomei and Li, Chang and Du, Yu and He, Yu},
title = {Optimal Compatibility of Main Effective Parts of Astragali Radix‐Safflower for the Treatment of Cerebral Ischemia/Reperfusion by Pharmacokinetics‐Pharmacodynamics Analysis Based on Microdialysis and Liquid Chromatography–Tandem Mass Spectrometry},
journal = {Phytochemical Analysis},
year = {2026},
doi = {10.1002/pca.70055}
}
EUVIMED